These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 33955162)
1. Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects. Shimizu H; Nishimura Y; Shiide Y; Yoshida K; Hirai M; Matsuda M; Nakamaru Y; Kato Y; Kondo K Clin Pharmacol Drug Dev; 2021 Oct; 10(10):1188-1197. PubMed ID: 33955162 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of Edaravone Oral Suspension in Patients With Amyotrophic Lateral Sclerosis. Shimizu H; Nishimura Y; Shiide Y; Akimoto M; Yashiro M; Ueda M; Hirai M; Yoshino H; Mizutani T; Kanai K; Kano O; Kimura H; Sekino H; Ito K Clin Ther; 2023 Dec; 45(12):1251-1258. PubMed ID: 37953075 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of Pharmacokinetics, Safety, and Drug-Drug Interactions of an Oral Suspension of Edaravone in Healthy Adults. Shimizu H; Nishimura Y; Shiide Y; Matsuda H; Akimoto M; Matsuda M; Nakamaru Y; Kato Y; Kondo K Clin Pharmacol Drug Dev; 2021 Oct; 10(10):1174-1187. PubMed ID: 33704925 [TBL] [Abstract][Full Text] [Related]
4. Edaravone Administered Orally and Via Nasogastric Tube in Healthy Adults: A Comparative Bioavailability Phase 1 Study. Shimizu H; Nishimura Y; Shiide Y; Ueda M; Yokota S; Kato Y; Hirai M Clin Pharmacol Drug Dev; 2023 Jan; 12(1):77-84. PubMed ID: 36225132 [TBL] [Abstract][Full Text] [Related]
5. Food Effect Study to Assess the Impact on Edaravone Pharmacokinetic Profiles in Healthy Participants. Shimizu H; Nishimura Y; Shiide Y; Akimoto M; Matsuda H; Kato Y; Hirai M Clin Ther; 2022 Dec; 44(12):1552-1565. PubMed ID: 36376130 [TBL] [Abstract][Full Text] [Related]
6. Bioavailability of Edaravone Sublingual Tablet Versus Intravenous Infusion in Healthy Male Volunteers. Wang J; Chen X; Yuan B; Wang W; Xu C; Zhao W; Zhao P; Wang Y; Zhao X; Wang Y Clin Ther; 2018 Oct; 40(10):1683-1691. PubMed ID: 30241688 [TBL] [Abstract][Full Text] [Related]
7. Edaravone Oral Suspension: A Neuroprotective Agent to Treat Amyotrophic Lateral Sclerosis. Singh P; Belliveau P; Towle J; Neculau AE; Dima L Am J Ther; 2024 May-Jun 01; 31(3):e258-e267. PubMed ID: 38691665 [TBL] [Abstract][Full Text] [Related]
8. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912 [TBL] [Abstract][Full Text] [Related]
9. Eslicarbazepine acetate (BIA 2-093) : relative bioavailability and bioequivalence of 50 mg/mL oral suspension and 200mg and 800mg tablet formulations. Fontes-Ribeiro C; Nunes T; Falcão A; Neta C; Lima R; Tavares S; Almeida L; Macedo T; Soares-da-Silva P Drugs R D; 2005; 6(5):253-60. PubMed ID: 16128595 [TBL] [Abstract][Full Text] [Related]
10. The Bioequivalence Between Valsartan Oral Solution and Suspension Formulations Developed for Pediatric Use. Sivasubramanian R; Sunkara G; Karan R; Zhou W; Zhang Y; Sangana R Clin Pharmacol Drug Dev; 2022 Jul; 11(7):843-848. PubMed ID: 35050548 [TBL] [Abstract][Full Text] [Related]
11. An Open-Label Crossover Study of the Pharmacokinetics of the 60-mg Edoxaban Tablet Crushed and Administered Either by a Nasogastric Tube or in Apple Puree in Healthy Adults. Duchin K; Duggal A; Atiee GJ; Kidokoro M; Takatani T; Shipitofsky NL; He L; Zhang G; Kakkar T Clin Pharmacokinet; 2018 Feb; 57(2):221-228. PubMed ID: 28512699 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of Absolute Oral Bioavailability and Bioequivalence of Ribociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, in Healthy Subjects. Ji Y; Abdelhady AM; Samant TS; Yang S; Rodriguez Lorenc K Clin Pharmacol Drug Dev; 2020 Oct; 9(7):855-866. PubMed ID: 32706937 [TBL] [Abstract][Full Text] [Related]
13. Predicting the Pharmacokinetic Characteristics of Edaravone Intravenous Injection and Sublingual Tablet Through Modeling and Simulation. Chen X; Sun Z; Wang J; Liang W; Zhao X; Wang Y; Wang Y Clin Ther; 2020 Mar; 42(3):428-438. PubMed ID: 32037096 [TBL] [Abstract][Full Text] [Related]
14. A new esomeprazole packet (sachet) formulation for suspension: in vitro characteristics and comparative pharmacokinetics versus intact capsules/tablets in healthy volunteers. Bladh N; Blychert E; Johansson K; Backlund A; Lundin C; Niazi M; Pettersson G; Fjellman M Clin Ther; 2007 Apr; 29(4):640-9. PubMed ID: 17617287 [TBL] [Abstract][Full Text] [Related]
15. Bioequivalence of 2 Aripiprazole Orally Disintegrating Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions. Xiang J; Xu N; Wang X; Li S; Yu Q; Liang M; Nan F; Shu S; Yan R; Zhu Y; Liao L Clin Pharmacol Drug Dev; 2021 Aug; 10(8):840-849. PubMed ID: 34105265 [TBL] [Abstract][Full Text] [Related]
16. Bioavailability and bioequivalence comparison of brivaracetam 10, 50, 75, and 100 mg tablets and 100 mg intravenous bolus. Stockis A; Hartstra J; Mollet M; Hadi S Epilepsia; 2016 Aug; 57(8):1288-93. PubMed ID: 27346728 [TBL] [Abstract][Full Text] [Related]
17. A randomized, open-label, crossover study evaluating bioequivalence of two N-acetylcysteine 2% oral solution formulations in healthy subjects . Donath F; Armogida M; Shneyer L Int J Clin Pharmacol Ther; 2018 Sep; 56(9):417-425. PubMed ID: 29956648 [TBL] [Abstract][Full Text] [Related]
18. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions. Chen C; Bujanover S; Kareht S; Rapoport AM Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and bioequivalence comparison of a single 100-mg dose of cefteram pivoxil powder suspension and tablet formulations: a randomized-sequence, open-label, two-period crossover study in healthy Chinese adult male volunteers. Zou J; Di B; Wu CY; Hu Q; Li JH; Zhu Y; Fan H; Xiao D; Wang GJ Clin Ther; 2008 Apr; 30(4):654-60. PubMed ID: 18498914 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, Safety and Bioequivalence of Levetiracetam Intravenous Infusion and Oral Tablets in Healthy Chinese Subjects. Toublanc N; Du X; Liu Y; Chen Q; Singh P; Chan R; Stockis A Clin Drug Investig; 2015 Aug; 35(8):495-503. PubMed ID: 26135593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]